Cargando…
Correction to: Melatonin and urological cancers: a new therapeutic approach
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523325/ https://www.ncbi.nlm.nih.gov/pubmed/33005099 http://dx.doi.org/10.1186/s12935-020-01564-6 |
_version_ | 1783588364479365120 |
---|---|
author | Pourhanifeh, Mohammad Hossein Hosseinzadeh, Azam Juybari, Kobra Bahrampour Mehrzadi, Saeed |
author_facet | Pourhanifeh, Mohammad Hossein Hosseinzadeh, Azam Juybari, Kobra Bahrampour Mehrzadi, Saeed |
author_sort | Pourhanifeh, Mohammad Hossein |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7523325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75233252020-09-30 Correction to: Melatonin and urological cancers: a new therapeutic approach Pourhanifeh, Mohammad Hossein Hosseinzadeh, Azam Juybari, Kobra Bahrampour Mehrzadi, Saeed Cancer Cell Int Correction BioMed Central 2020-09-28 /pmc/articles/PMC7523325/ /pubmed/33005099 http://dx.doi.org/10.1186/s12935-020-01564-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Pourhanifeh, Mohammad Hossein Hosseinzadeh, Azam Juybari, Kobra Bahrampour Mehrzadi, Saeed Correction to: Melatonin and urological cancers: a new therapeutic approach |
title | Correction to: Melatonin and urological cancers: a new therapeutic approach |
title_full | Correction to: Melatonin and urological cancers: a new therapeutic approach |
title_fullStr | Correction to: Melatonin and urological cancers: a new therapeutic approach |
title_full_unstemmed | Correction to: Melatonin and urological cancers: a new therapeutic approach |
title_short | Correction to: Melatonin and urological cancers: a new therapeutic approach |
title_sort | correction to: melatonin and urological cancers: a new therapeutic approach |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523325/ https://www.ncbi.nlm.nih.gov/pubmed/33005099 http://dx.doi.org/10.1186/s12935-020-01564-6 |
work_keys_str_mv | AT pourhanifehmohammadhossein correctiontomelatoninandurologicalcancersanewtherapeuticapproach AT hosseinzadehazam correctiontomelatoninandurologicalcancersanewtherapeuticapproach AT juybarikobrabahrampour correctiontomelatoninandurologicalcancersanewtherapeuticapproach AT mehrzadisaeed correctiontomelatoninandurologicalcancersanewtherapeuticapproach |